Cargando…

Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle

Detalles Bibliográficos
Autores principales:	Popowicz, Grzegorz Maria, Pyrc, Krzysztof, Hadian, Kamyar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044391/ https://www.ncbi.nlm.nih.gov/pubmed/35477929 http://dx.doi.org/10.1038/s41392-022-01000-3

Ejemplares similares

Battle at the entrance gate: CIITA as a weapon to prevent the internalization of SARS-CoV-2 and Ebola viruses
por: Butowt, Rafal, et al.
Publicado: (2020)

Boosting with variant-matched vaccines: an opportunity to win the race against Omicron
por: Wang, Jiayu, et al.
Publicado: (2022)

SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine
por: Zhang, Xiantao, et al.
Publicado: (2022)

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
por: Li, Maochen, et al.
Publicado: (2022)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

Modification of the susceptibility gene TaPsIPK1 - a win-win for wheat disease resistance and yield
por: Macho, Alberto, et al.
Publicado: (2022)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Keeping track of the SARS-CoV-2 vaccine pipeline
por: Parker, Edward P. K., et al.
Publicado: (2020)

Winning the battle of refractory hypotony
por: Maheshwari, Devendra, et al.
Publicado: (2022)

Food for thought: Autophagy researcher wins 2016 Nobel Prize in Physiology or Medicine
por: Walton, Emma Louise
Publicado: (2017)

Fungal clones win the battle, but recombination wins the war
por: Drenth, André, et al.
Publicado: (2019)

SARS-CoV-2 vaccines: anamnestic response in previously infected recipients
por: Purushotham, Jyothi N., et al.
Publicado: (2021)

SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
por: Noh, Ji Yun, et al.
Publicado: (2021)

SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread
por: Wang, Xinling, et al.
Publicado: (2023)

Structural insights into the Omicron spike trimer: tackling the challenges of continuously evolving SARS-CoV-2 variants
por: Ou, Junxian, et al.
Publicado: (2022)

Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine
por: Peng, Hua, et al.
Publicado: (2022)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
por: Wang, Qiao, et al.
Publicado: (2023)

At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
por: Singanallur, Nagendrakumar B., et al.
Publicado: (2022)

India’s ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?
por: Sulis, Giorgia, et al.
Publicado: (2022)

Characterization of SARS-CoV-2 replication complex elongation and proofreading activity
por: Jones, Alisha N., et al.
Publicado: (2022)

Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants
por: Pawelec, Graham, et al.
Publicado: (2021)

COVID-19: losing battles or winning the war?
por: Reperant, Leslie A., et al.
Publicado: (2020)

Hide and seek with SARS-CoV-2: spike receptor-binding domain-specific memory B cells still recognize Omicron variant
por: Odak, Ivan, et al.
Publicado: (2022)

SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency
por: Li, Maochen, et al.
Publicado: (2021)

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein
por: Wang, Junzhi
Publicado: (2020)

A promiscuous interaction of SARS-CoV-2 with bacterial products
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Virtual Issue on SARS-CoV-2: Evolution of a Pandemic
por: McGrath, Casey
Publicado: (2023)

Cancer-host battles: measures and countermeasures in radiation-induced caspase activation and tumor immunogenicity
por: Rosado, M. M., et al.
Publicado: (2020)

Explorative probes and biomarkers, chronic Salmonella infections and future vaccines
por: Michán, Carmen, et al.
Publicado: (2012)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus
por: Wang, Junzhi
Publicado: (2021)

Selective Antimicrobial Therapies for Periodontitis: Win the “Battle and the War”
por: Elashiry, Mahmoud, et al.
Publicado: (2021)

The battle against perioperative glycaemic control: Hard to win?
por: Parthasarathy, S., et al.
Publicado: (2022)

Plasmodium falciparum finds the winning combination
por: Hengge, Alvan C.
Publicado: (2021)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control
por: Yang, Jianshe
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6omv9plr1s7g6g1s7dicnfe90k